Edward P. Havranek, MD
Havranek EP. Simvastatin reduced major vascular events at 5 years in at-risk patients; benefits were maintained at 11 years. Ann Intern Med. 2012;156:JC3–5. doi: https://doi.org/10.7326/0003-4819-156-6-201202210-02005
Download citation file:
Published: Ann Intern Med. 2012;156(6):JC3-5.
Cardiology, Coronary Risk Factors, Dyslipidemia.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use